Issued Patents All Time
Showing 1–25 of 50 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 4835313 | (5,6-dichloro-3-oxo-9.alpha.-propyl-2,3,9,9.alpha.-tet rahydrofluoren-7-yl) alkanimidamides | Adolph M. Pietruszkiewicz, Edward J. Cragoe, Jr. | 1989-05-30 |
| 4797391 | ((5,6-dichloro-3-oxo-9,9a-d isubstituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy)alkanoic acids and alkanimidamides | Edward J. Cragoe, Jr., Adolph M. Pietruszkiewicz | 1989-01-10 |
| 4777281 | [3,4-dichloro-6,7,8,8a,9,10-hexahydro-6-oxo-8a-substituted-2-phenanthreny l)oxy]-alkanoic acids and -ethanimidamides | Edward J. Cragoe, Jr. | 1988-10-11 |
| 4775695 | Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof | Edward J. Cragoe, Jr. | 1988-10-04 |
| 4769370 | (1,2-dichloro-8-oxo-5a-substituted-5a,6,7,8 -tetrahydrodibenzofuran-3-yl)alkanoic acids and alkanimidamides | Edward J. Cragoe, Jr. | 1988-09-06 |
| 4754061 | Substituted (2,3-dihydro-1-oxo-1H-inden-5-yl)alkanoic acids, their derivatives and their salts | Edward J. Cragoe, Jr. | 1988-06-28 |
| 4751244 | Compounds useful in treating sickle cell anemia | Donald J. Abraham, Edward J. Cragoe, Jr. | 1988-06-14 |
| 4731473 | Compounds useful in treating sickle cell anemia | Donald J. Abraham, Edward J. Cragoe, Jr. | 1988-03-15 |
| 4731381 | Method of treating a person for sickle cell anemia | Donald J. Abraham, Edward J. Cragoe, Jr. | 1988-03-15 |
| 4731470 | [(5,6-dichloro-3-oxo-2,9a-alkano-2,3,9,9a-tetrahydro-1H-fluoren-7-yl)oxy] alkanoic acids and alkanimidamides | Adolph M. Pietruszkiewicz, Edward J. Cragoe, Jr. | 1988-03-15 |
| 4731471 | (5,6-dichloro-3-oxo-2,3,9,9a-tetrahydrofluoren-7-yl)-alkanoic acids and alkanimidamides bearing novel functional 9a-substituents | Edward J. Cragoe, Jr., Adolph M. Pietruszkiewicz | 1988-03-15 |
| 4731472 | (5,6-dichloro-3-oxo-9A-propyl-2,3,9,9A-tetrahydrofluoren-7-yl)alkanoic acids and alkanimidamides | Adolph M. Pietruszkiewicz, Edward J. Cragoe, Jr. | 1988-03-15 |
| 4719310 | Ester and amide substituted (2,3-dihydro-4-(3-oxo-1-cyclohexen-1-yl)phenoxy)alkanoic acids and their salts | Adolph M. Pietruszkiewicz, Edward J. Cragoe, Jr. | 1988-01-12 |
| 4699926 | Compounds useful in treating sickle cell anemia | Donald J. Abraham, Edward J. Cragoe, Jr. | 1987-10-13 |
| 4680414 | Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones | Edward J. Cragoe, Jr. | 1987-07-14 |
| 4654365 | 2,3-dihydro-5-(3-oxo-2-cyclohexen-1-yl)-2-benzofurancarboxylic acids, and their salts useful in the treatment of brain injury | Edward J. Cragoe, Jr. | 1987-03-31 |
| 4634717 | Substituted-3- (2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema | Edward J. Cragoe, Jr. | 1987-01-06 |
| 4625047 | Substituted (2,3-dihydro-4-(3-oxo-1-cyclohexen-1-yl)phenoxy) alkanoic acids, their derivatives and their salts | Edward J. Cragoe, Jr., Adolph M. Pietruszkiewicz | 1986-11-25 |
| 4605664 | Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-dione s for treatment of grey matter edema | Edward J. Cragoe, Jr. | 1986-08-12 |
| 4605663 | Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-dione s, for treatment of grey matter edema | Edward J. Cragoe, Jr. | 1986-08-12 |
| 4604403 | Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema | Edward J. Cragoe, Jr. | 1986-08-05 |
| 4604396 | [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]ethanimida mides and [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]ethanimid ic acid hydrazides, their derivatives and their salts | Edward J. Cragoe, Jr. | 1986-08-05 |
| 4596821 | Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones | Edward J. Cragoe, Jr. | 1986-06-24 |
| 4579869 | Substituted [(2,3-dihydro-1-oxo-1H-inden-5-yl)amino]alkanoic acids, their derivatives and their salts | Edward J. Cragoe, Jr. | 1986-04-01 |
| 4505923 | Ethers of hydroxybenzothiazole-2-sulfonamide for the topical treatment of elevated intraocular pressure | Jacob M. Hoffman | 1985-03-19 |